Fertility

Ro Acquires Modern Fertility to Accelerate Its Leadership in Women’s Health

Healthtech company Ro today announced the acquisition of femtech company Modern Fertility, a high-growth reproductive health company focused on addressing gaps in women’s healthcare through fertility testing, research, education, and community. Since 2017, Modern Fertility has empowered people with ovaries nationwide to play a more active role in their health and build the lives they want on their own terms.  The acquisition represents…

Tulip’s Gail Sexton Anderson: “We want our platform to be a trusted source for all intended parents and the go-to place for third party fertility.”

Tulip, the world’s largest egg donor database and trusted resource for intended parents to find their ideal donor, has recently announced the closing of a $1.7M seed round. Launched in November of 2020, Tulip has quickly amassed donors from 90% of the agencies in the U.S. with nearly 20,000 egg donors within its database. The user-friendly, online search platform today helps intended…

Launched: Famlee Introduces Its At-Home Digital Fertility Protocol

Famlee, a digital fertility solution, announced today thelaunch of its all-in-one at-home fertility protocol that prepares a woman’s body for baby, including 50-state fertility telehealth, 14-hormone at-home lab testing, customized prescriptions, a fertility tracking mobile app and more. One in eight women will experience fertility complications. 30-35% of these complications are attributed to hormone imbalances and another 30% of “unexplained infertility” is often…

Israeli Fertility Startup AiVF Receives CE Clearance

Israel-based startup AiVF has received the European CE Mark which now allows the company to market throughout the European Union. The company has developed technology based on AI, computer vision and big data analytics to help improve iVF outcomes. Professor Daniel Seidman, MD, co-founder and Chief Medical Officer at AiVF, noted: “Traditional embryo evaluation technique is performed manually and is not AI…

Medical Device Company INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for INVOcell, its Infertility Solution

INVO Bioscience, a medical device company focused on commercializing the world’s only in vivo Intravaginal Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, is pleased to announce the appointment of tenured women’s health & fertility solution marketing professional, Meryle Lynn Chamberlain, as Director of Marketing, a newly created position within the company. Chamberlain brings over 15 years of…

Alife Health raises a $9M Seed Round to Improve IVF Outcomes

1 in 8 families now struggle with infertility. Studies show that the average healthy couple has a 20 percent natural fertility rate per cycle, and miscarriages in women are increasing by about 1 percent each year. Additionally, Black and Latinx women are less likely to access fertility care and have a successful IVF pregnancy. As fertility continues to be in crisis, new artificial…

Carrot Fertility and Legacy Partner to Expand Access to Male Fertility Care

Legacy, a digital fertility clinic for men, today announced a new partnership with the global fertility benefits provider for employers, Carrot Fertility. Carrot Fertility is the trusted global fertility benefits solution for more than 200 companies including Box, Snap, Inc., and Peloton. The new partnership provides Carrot members in the U.S. with exclusive, discounted access to Legacy’s at-home sperm analysis and cryopreservation services.…

Presagen’s Life Whisperer: Artificial Intelligence Helps IVF Patients Avoid Invasive Embryo Genetic Testing

Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A genetic testing requires a portion of a healthy embryo to be removed and sent away for testing. The procedure is invasive, costly, and potentially risky. Presagen CEO, Dr Michelle Perugini said:…